Last $108.36 USD
Change Today -0.06 / -0.06%
Volume 1.0M
BMRN On Other Exchanges
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Henry J. Fuchs M.D., Ph.D.

Chief Medical Officer and Executive Vice President, BioMarin Pharmaceutical Inc.
AgeTotal Calculated CompensationThis person is connected to 38 board members in 3 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Henry J. Fuchs, also known as Hank, M.D., Ph.D. has been the Chief Medical Officer of BioMarin Pharmaceutical Inc. since March 2, 2009 and serves as its Executive Vice President. Dr. Fuchs served as Senior Vice President of BioMarin Pharmaceutical Inc. since March 2, 2009 until December 2009. Dr. Fuchs served as the Chief Medical Officer and Executive Vice President of Onyx Pharmaceuticals, Inc. from September 19, 2005 to December 1, 2008. He was responsible for ...

Read Full Background

Corporate Headquarters*

770 Lindaro Street
San Rafael, California 94901

United States

Phone: 415-506-6700
Fax: 415-382-7889

Board Members Memberships*

Former Chief Operating Officer and Director
Former Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Former Independent Director, Chairman of Scientific Committee and Member of Compensation Committee
Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
Former Director


Harvard University
George Washington University
PhD 1975
The University of Utah

Other Affiliations*

Annual Compensation*

Total Annual Compensation$631,883

Stock Options*

Restricted Stock Awards$1,057,836
All Other Compensation$8,488
Exercised Options60,000
Exercised Options Value$3,361,259
Exercisable Options164,728
Exercisable Options Value$6,781,937
Unexercisable Options152,272
Unexercisable Options Value$3,111,723
Total Value of Options$13,254,919
Total Number of Options377,000

Total Compensation*

Total Annual Cash Compensation$940,266
Total Short Term Compensation$631,883
Other Long Term Compensation$1,066,324
Total Calculated Compensation$4,825,472
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BMRN:US $108.36 USD -0.06


Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
John F. Thero Chief Executive Officer, President, Assistant Secretary and Director
Amarin Corporation plc
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOMARIN PHARMACEUTICAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at